High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$465K
$465,711
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
GEMAYEL GEORGES
• Director
Discretionary SellΔOwn -24.4%
2026-03-06
$465,711
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -24.4%
|
2026-03-06 | $465,711 | S | Form 4 |